DEMOGRAPHICS and O2 Age M/F ratio pk yr BMI Exac Prev Yr Oxygen use
High Risk (n=16) 60.2(9.5) 10/6 59.1(30.6) 26.1(3.5) 0.50(0.61) 5/16
Low Risk (n=13) 61.3(7.0) 9/4 36.8(19.4) 24.5(3.3) 0.77(0.72) 5/13
p 0.76   0.02 0.35 0.14  
MEDICATION USE SABA LABA SAAC LAAC ICS Phosphodisterase Inhibitor
High Risk (n=16) 12.5% 81.3% 0,00% 87.5% 68.8% 6.3%
Low Risk (n=13) 23.1% 100.00% 15.3% 69.2% 92.3% 15.3%
p            
Baseline physiology Baseline RV (% pred) RV/TLC FEV1 (% pred) DLco (% pred) 6 MWT (meters) MRCD (units) BODE index
High Risk (n=16) 216.5(66.3) 0.61(0.11) 35.1(9.1) 40.8(18.4) 345(123) 3.0(0.5) 5.4(1.6)
Low Risk (n=13) 233.6(68.3) 0.61(0.13) 30.3(6.7) 37.8(19.0) 353(120) 3.0(0.5) 5.7(1.2)
p 0.46 0.95 0.09 0.69 0.88 1.0 0.52
Table 2: Comparison of baseline demographics, medical use, and physiology of “High Risk” and “Low Risk” subgroups based on pre-treatment CRP values.